Valuation: QuidelOrtho Corporation

Market Cap 1.09B 962M 896M 823M 1.54B 105B 1.56B 10.65B 4.16B 51.83B 4.11B 4.02B 179B P/E 2026 *
-10x
P/E 2027 * -100x
Enterprise Value 3.46B 3.04B 2.83B 2.6B 4.89B 332B 4.95B 33.69B 13.16B 164B 13B 12.72B 567B EV / Sales 2026 *
1.28x
EV / Sales 2027 * 1.21x
Free-Float
99.1%
Yield 2026 *
-
Yield 2027 * -
1 day+4.86%
1 week-3.16%
Current month-3.91%
1 month+22.04%
3 months+45.21%
6 months-41.32%
Current year-41.07%
1 week 15.54
Extreme 15.545
17.5
1 month 15.49
Extreme 15.49
19.8
Current year 9.92
Extreme 9.92
35.58
1 year 9.92
Extreme 9.92
35.58
3 years 9.92
Extreme 9.92
88.14
5 years 9.92
Extreme 9.92
180.06
10 years 9.92
Extreme 9.92
306.72
Manager TitleAgeSince
Chief Executive Officer 61 2024-05-05
Director of Finance/CFO 48 2026-07-05
Chief Tech/Sci/R&D Officer 44 2024-10-06
Director TitleAgeSince
Chairman 72 2022-12-10
Director/Board Member 71 2021-12-31
Director/Board Member 82 1992-12-31
Date Insider Type Main position Quantity % Market Cap.
7/15/26 Free

Chief Financial Officer

356,555 0.5251%
7/6/26 Other

Chief Financial Officer

0 0%
7/1/26 Fiscal year

EVP Global Port. Mgmt & Mkting

13,690 0.0202%
Change 5-day change 1-year change 3-year change Capi.($)
+4.86%-3.16%-38.55%-80.93% 1.09B
-3.03%-11.96%+12.14%-40.07% 15.54B
+4.07%+9.27%+1.83%+92.76% 1.65B
+1.20%-3.51%-37.83%+14.00% 948M
+3.70%-2.12%-43.46%-54.33% 609M
+1.10%-4.29%-50.51%-58.91% 505M
+0.55%+4.08%+39.87%-52.18% 460M
+1.49%-2.55%-56.83%-60.34% 365M
+1.29%-3.67%-21.13%-35.69% 344M
+0.44%-5.99%+48.60% - 315M
Average +1.75%-2.45%-14.59%-30.63% 2.18B
Weighted average by Cap. -0.76%-6.73%+3.08%-30.98%

Financials

2026 *2027 *
Net sales 2.71B 2.38B 2.22B 2.04B 3.82B 260B 3.87B 26.36B 10.3B 128B 10.17B 9.95B 444B 2.8B 2.46B 2.29B 2.1B 3.95B 268B 4B 27.23B 10.63B 133B 10.51B 10.28B 458B
Net income -156M -137M -128M -117M -220M -14.95B -223M -1.52B -592M -7.38B -585M -572M -25.51B -81.93M -72.03M -67.05M -61.58M -116M -7.86B -117M -797M -311M -3.88B -308M -301M -13.41B
Net Debt 2.37B 2.08B 1.94B 1.78B 3.34B 227B 3.39B 23.04B 9B 112B 8.89B 8.7B 388B 2.3B 2.02B 1.88B 1.73B 3.24B 220B 3.29B 22.36B 8.73B 109B 8.63B 8.44B 376B
Logo QuidelOrtho Corporation
QuidelOrtho Corporation provides in vitro diagnostics, developing and manufacturing intelligent solutions. The Company specializes in immunoassay and molecular testing, clinical chemistry and transfusion medicine. Its business units include labs, molecular diagnostics, point of care and transfusion medicine. Under the labs business unit, its product categories include virology & bioassays, specialty products, VITROS platform and immunodiagnostics. Under the molecular diagnostics business unit, its product categories include Lyra, Solana and Savanna. Under the point of care business unit, its product categories include rapid immunoassay and cardiometabolic immunoassay. Under the transfusion medicine business unit, its product categories include immunohematology and donor screening. It provides diagnostic testing solutions under various brand names, including AdenoPlus, BIOVUE, FreshCells, InflammaDry, Lyra, MeterPro, MicroVue, Ortho, Ortho Clinical Diagnostics, Ortho Optix and others.
Employees
6,500
Date Price Change Volume
26-07-27 US$16.83 +4.86% 1,035,326
26-07-24 US$16.05 -3.20% 913,043
26-07-23 US$16.58 -0.60% 806,537
26-07-22 US$16.68 +1.52% 1,257,035
26-07-21 US$16.43 -0.90% 1,274,873
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
4
Last Close Price
16.05USD
Average target price
20.50USD
Spread / Average Target
+27.73%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. QDEL Stock